 |
|
 |
- September 8, 2010 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Biography |
|
|
Dr. Barry Goldstein
Barry J. Goldstein, MD, PhD
Professor of Medicine, Biochemistry and Molecular Pharmacology
Jefferson Medical College of Thomas Jefferson University
Director of the Division of Endocrinology, Diabetes and Metabolic Diseases
Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.
Dr. Goldstein received a bachelor’s of science degree with distinction from Cornell University in New York City, where he concentrated in biochemistry and genetics, and graduated with honors from the Medical Scientist Training Program (MD/PhD Biochemistry) of the University of Rochester School of Medicine and Dentistry in Rochester, New York. Following a medical residency at Strong Memorial Hospital in Rochester, Dr. Goldstein completed research and clinical fellowships at Harvard Medical School in the Section on Cellular and Molecular Physiology of the Joslin Diabetes Center and in the Division of Endocrinology, Diabetes and Metabolism at Brigham and Women's Hospital in Boston. After serving as an Assistant Professor at Harvard and a Research Investigator in the Joslin Research Laboratories, Dr. Goldstein moved to Philadelphia, where he assumed his current role at Jefferson Medical College.
Dr. Goldstein maintains active basic and clinical research programs, with interests centered on the mechanisms and regulation of insulin signal transduction, especially the pathophysiology of insulin resistant disease states, including obesity and type 2 diabetes. Recently, his laboratory has been interested in the vascular signaling effects of the abundant adipose-specific secreted protein adiponectin. He has authored more than 150 papers in basic and clinical research, as well as reviews and textbook chapters. He is frequently invited to lecture at national conferences and international symposia.
Dr. Goldstein is a Fellow of the American College of Endocrinology (FACE), and has been elected to membership in the American Society for Clinical Investigation (ASCI), the Interurban Clinical Club and the Association of American Physicians (AAP). He is an Associate Editor for Diabetes and until recently also served as an Associate Editor of the Journal of Clinical Endocrinology and Metabolism and on the Editorial Board of Current Drug Targets in Immune, Endocrine & Metabolic Disorders. He is a past president of both the Philadelphia Endocrine Society and the Philadelphia Affiliate of the American Diabetes Association and a former member of the Subspecialty Board on Endocrinology, Diabetes and Metabolism of the American Board of Internal Medicine.
|
| |
List of presentations from this healthcare provider available on CMEonDiabetes :
 Identifying Metabolic Syndrome as a Risk Factor for Type 2 Diabetes:...
english - 2004-11-08 - 44 minutes
Adiponectin - Novel 'Adipokine' with Metabolic and Vascular Effects
english - 2005-04-27 - 54 minutes
|
|
|
|
|
| Social |
 |
| |
Let others know about this biography.
|
|
| Search our website |
|
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
|
|
